MedTrace Logo

App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3

NCT06322992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2025-02-05

No results posted yet for this study

Summary

The goal of this observational study is to develop a mobile app for cancer patients undergoing treatments. In Aim 3, patients will rate the quality of the app using the Mobile App Rating Scale (MARS) and their satisfaction with the three key app features. The outcome of this project will be a final prototype app with 70% of patients indicating an overall MARS score of 4.0 or more and satisfaction with the three features.

Conditions

Sponsors & Collaborators

  • Masonic Cancer Center, University of Minnesota

    collaborator OTHER

  • Daynamica, Inc.

    lead INDUSTRY

Principal Investigators

  • Yingling Fan · Daynamica, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-14
Primary Completion
2024-10-20
Completion
2024-10-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06322992 on ClinicalTrials.gov